News

Latest news

Hide mandatory notifications of trade

New Primary insiders in NUT 19 February 2010

19.02.2010 - Reference is made to the stock exchange notification published by 18 February 2010 regarding primary insiders in Nutri Pharma ASA ("NUT")

This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
Reference is made to the stock exchange notification published by 18 February
2010 regarding primary insiders in Nutri Pharma ASA ("NUT").

In addition to the primary insiders described in the stock notice of 18 February
2010, certain key employees of Bionor Immuno AS ("Bionor") have subscribed for
shares in NUT in the Private Placement and been allocated shares in the Bionor
Placement.

Birger Sørensen will be appointed as general manager of Bionor with effect from
19 February 2010. On 18 February 2010, Sørensen was allocated 265 000 shares in
NUT in connection with the Private Placement. Sørensen has also received
833 667 shares in NUT as consideration for his shares in Bionor in connection
with the Bionor Placement.

Various persons and companies related to Birger Sørensen in accordance with the
Norwegian Securities Trading Act section 2-5 item 1, 2, and 4, have been
allocated shares in NUT in connection with the Bionor Placement, in total
3 085 000 shares in NUT.

Birger Sørensen, through related persons as described in the Norwegian
Securities Trading Act section 2-5 item 1, 2, and 4, currently holds 4 183 667
shares in NUT.

Per Bengtsson, Senior Vice President Development, was allocated 200 000 shares
in NUT as consideration for his shares in Bionor in connection with the Bionor
Placement. Bengtsson currently holds 200 000 shares in NUT.

This notification is sent by the company on behalf of the persons above, in
connection with the closing of the Private Placement and the Bionor Placement by
NUT.

Following the issue of shares in the Private Placement and Bionor Placement, NUT
has 180 425 891 issued and outstanding shares.